6533b7d7fe1ef96bd1268e31

RESEARCH PRODUCT

Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients

Ion AnghelescuDan RujescuChristoph HiemkeMatthias J. MüllerSabine GermeyerNobert DahmenHermann Wetzel

subject

Psychiatry and Mental healthText miningNeuroleptic drugbusiness.industryDopamine receptor D3Dopamine receptor D2MedicinePharmacologybusinessBiological Psychiatryhttps://doi.org/10.1016/s0920-9964(99)00147-4